Chargement en cours...
No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients
The influence of treatment with alendronate (ALN), teriparatide (TPTD) or concurrent treatment with both on the human bone matrix mineralization has not yet been fully elucidated. For this purpose we analyzed quadruple fluorochrome labelled transiliac bone biopsy samples (n = 66) from postmenopausal...
Enregistré dans:
| Publié dans: | Bone Rep |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7090359/ https://ncbi.nlm.nih.gov/pubmed/32215284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100253 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|